// =============================================================================
// SOMA Infecciosas Enciclopedia — Spanish-First Bilingual
// Infectious Diseases & STI Patient Education Content
// =============================================================================
// ARCHITECTURE: JSON.parse() wrapper prevents TS2590 "expression too complex"
// =============================================================================

export interface InfecciosaEntry {
  id: string;
  nombreEs: string;
  nombreEn: string;
  categoriaEs: string;
  categoriaEn: string;
  agenteEs: string;
  agenteEn: string;
  descripcionEs: string;
  descripcionEn: string;
  sintomasEs: string[];
  sintomasEn: string[];
  transmisionEs: string[];
  transmisionEn: string[];
  diagnosticoEs: string[];
  diagnosticoEn: string[];
  tratamientoEs: string[];
  tratamientoEn: string[];
  prevencionEs: string[];
  prevencionEn: string[];
  complicacionesEs: string[];
  complicacionesEn: string[];
  datosClaveEs: string[];
  datosClaveEn: string[];
  esITS?: boolean;
  vacunaDisponible?: boolean;
}

export const infecciosasEnciclopedia: InfecciosaEntry[] = JSON.parse(`[
  {"id":"inf-influenza","nombreEs":"Influenza (Gripe)","nombreEn":"Influenza (Flu)","categoriaEs":"Respiratoria","categoriaEn":"Respiratory","agenteEs":"Virus de influenza A, B o C","agenteEn":"Influenza virus A, B or C","descripcionEs":"Infeccion viral respiratoria aguda altamente contagiosa. Causa epidemias estacionales y puede ser grave en poblaciones vulnerables como ancianos, ninos y embarazadas.","descripcionEn":"Highly contagious acute viral respiratory infection. Causes seasonal epidemics and can be severe in vulnerable populations like elderly, children, and pregnant women.","sintomasEs":["Fiebre alta de inicio subito","Dolor muscular y articular intenso","Tos seca","Dolor de cabeza severo","Fatiga extrema","Dolor de garganta","Congestion nasal"],"sintomasEn":["Sudden onset high fever","Intense muscle and joint pain","Dry cough","Severe headache","Extreme fatigue","Sore throat","Nasal congestion"],"transmisionEs":["Gotas respiratorias al toser o estornudar","Contacto con superficies contaminadas","Aerosoles en espacios cerrados"],"transmisionEn":["Respiratory droplets from coughing or sneezing","Contact with contaminated surfaces","Aerosols in enclosed spaces"],"diagnosticoEs":["Prueba rapida de influenza (resultado en 15-30 min)","PCR nasofaringeo (mas preciso)","Diagnostico clinico en temporada de influenza"],"diagnosticoEn":["Rapid influenza test (result in 15-30 min)","Nasopharyngeal PCR (more accurate)","Clinical diagnosis during flu season"],"tratamientoEs":["Oseltamivir (Tamiflu) dentro de las primeras 48 horas","Reposo e hidratacion abundante","Acetaminofen o ibuprofeno para fiebre y dolor","Antivirales en poblaciones de alto riesgo"],"tratamientoEn":["Oseltamivir (Tamiflu) within first 48 hours","Rest and abundant hydration","Acetaminophen or ibuprofen for fever and pain","Antivirals in high-risk populations"],"prevencionEs":["Vacuna anual contra influenza","Lavado de manos frecuente","Cubrir boca al toser con codo","Evitar contacto cercano con enfermos","Quedarse en casa si tiene sintomas"],"prevencionEn":["Annual influenza vaccine","Frequent handwashing","Cover mouth when coughing with elbow","Avoid close contact with sick people","Stay home if symptomatic"],"complicacionesEs":["Neumonia viral o bacteriana secundaria","Miocarditis","Encefalitis","Exacerbacion de enfermedades cronicas","Muerte en poblaciones vulnerables"],"complicacionesEn":["Viral or secondary bacterial pneumonia","Myocarditis","Encephalitis","Exacerbation of chronic diseases","Death in vulnerable populations"],"datosClaveEs":["Causa 3-5 millones de casos graves al ano mundialmente","La vacuna se actualiza cada ano por mutaciones del virus","El periodo de contagio es 1 dia antes a 5-7 dias despues del inicio de sintomas","Se diferencia del resfriado por la intensidad y rapidez de inicio"],"datosClaveEn":["Causes 3-5 million severe cases annually worldwide","Vaccine is updated yearly due to virus mutations","Contagious period is 1 day before to 5-7 days after symptom onset","Distinguished from common cold by intensity and rapid onset"],"vacunaDisponible":true},
  {"id":"inf-covid19","nombreEs":"COVID-19","nombreEn":"COVID-19","categoriaEs":"Respiratoria","categoriaEn":"Respiratory","agenteEs":"SARS-CoV-2 (coronavirus)","agenteEn":"SARS-CoV-2 (coronavirus)","descripcionEs":"Enfermedad respiratoria causada por el coronavirus SARS-CoV-2. Varia desde infeccion asintomatica hasta neumonia severa y falla multiorganica. El COVID prolongado puede causar sintomas persistentes por meses.","descripcionEn":"Respiratory disease caused by SARS-CoV-2 coronavirus. Ranges from asymptomatic infection to severe pneumonia and multiorgan failure. Long COVID can cause persistent symptoms for months.","sintomasEs":["Fiebre o escalofrios","Tos","Fatiga","Perdida del olfato o gusto","Dolor de garganta","Congestion nasal","Dificultad para respirar","Dolor muscular"],"sintomasEn":["Fever or chills","Cough","Fatigue","Loss of smell or taste","Sore throat","Nasal congestion","Difficulty breathing","Muscle pain"],"transmisionEs":["Aerosoles y gotas respiratorias","Contacto cercano prolongado","Espacios cerrados con mala ventilacion"],"transmisionEn":["Aerosols and respiratory droplets","Prolonged close contact","Enclosed spaces with poor ventilation"],"diagnosticoEs":["Prueba rapida de antigeno","PCR nasofaringeo","Pruebas caseras de autodiagnostico"],"diagnosticoEn":["Rapid antigen test","Nasopharyngeal PCR","Home self-diagnostic tests"],"tratamientoEs":["Antivirales (Paxlovid) en pacientes de alto riesgo dentro de 5 dias","Reposo e hidratacion","Acetaminofen para sintomas","Oxigeno suplementario en casos graves","Corticoides en pacientes hospitalizados con hipoxia"],"tratamientoEn":["Antivirals (Paxlovid) in high-risk patients within 5 days","Rest and hydration","Acetaminophen for symptoms","Supplemental oxygen in severe cases","Corticosteroids in hospitalized patients with hypoxia"],"prevencionEs":["Vacunacion y refuerzos actualizados","Ventilacion adecuada de espacios","Uso de mascarilla en situaciones de alto riesgo","Lavado de manos","Aislamiento si hay sintomas o prueba positiva"],"prevencionEn":["Updated vaccination and boosters","Adequate space ventilation","Mask use in high-risk situations","Handwashing","Isolation if symptomatic or test positive"],"complicacionesEs":["Neumonia severa y SDRA","Tromboembolismo","COVID prolongado (fatiga, niebla mental, disnea)","Sindrome inflamatorio multisistemico en ninos (MIS-C)","Miocarditis"],"complicacionesEn":["Severe pneumonia and ARDS","Thromboembolism","Long COVID (fatigue, brain fog, dyspnea)","Multisystem inflammatory syndrome in children (MIS-C)","Myocarditis"],"datosClaveEs":["El virus continua mutando con nuevas variantes","La vacunacion reduce significativamente hospitalizacion y muerte","COVID prolongado puede afectar a personas con infeccion leve","Factores de riesgo: edad avanzada, obesidad, diabetes, inmunosupresion"],"datosClaveEn":["Virus continues mutating with new variants","Vaccination significantly reduces hospitalization and death","Long COVID can affect people with mild infection","Risk factors: advanced age, obesity, diabetes, immunosuppression"],"vacunaDisponible":true},
  {"id":"inf-tuberculosis","nombreEs":"Tuberculosis (TB)","nombreEn":"Tuberculosis (TB)","categoriaEs":"Respiratoria","categoriaEn":"Respiratory","agenteEs":"Mycobacterium tuberculosis","agenteEn":"Mycobacterium tuberculosis","descripcionEs":"Infeccion bacteriana cronica que afecta principalmente los pulmones. Un tercio de la poblacion mundial tiene TB latente. Es una de las principales causas de muerte infecciosa a nivel mundial.","descripcionEn":"Chronic bacterial infection primarily affecting the lungs. One-third of the world population has latent TB. It is one of the leading causes of infectious death worldwide.","sintomasEs":["Tos cronica de mas de 2 semanas","Esputo con sangre (hemoptisis)","Fiebre vespertina","Sudoracion nocturna","Perdida de peso inexplicable","Fatiga cronica","Dolor toracico"],"sintomasEn":["Chronic cough of more than 2 weeks","Blood-tinged sputum (hemoptysis)","Evening fever","Night sweats","Unexplained weight loss","Chronic fatigue","Chest pain"],"transmisionEs":["Aerosoles al toser, estornudar o hablar","Contacto prolongado en espacios cerrados","NO se transmite por objetos o superficies"],"transmisionEn":["Aerosols when coughing, sneezing, or talking","Prolonged contact in enclosed spaces","NOT transmitted by objects or surfaces"],"diagnosticoEs":["Prueba de tuberculina (PPD/Mantoux)","Prueba de liberacion de interferon gamma (IGRA)","Radiografia de torax","Cultivo de esputo (confirmatorio)","GeneXpert/PCR para deteccion rapida"],"diagnosticoEn":["Tuberculin skin test (PPD/Mantoux)","Interferon-gamma release assay (IGRA)","Chest X-ray","Sputum culture (confirmatory)","GeneXpert/PCR for rapid detection"],"tratamientoEs":["TB latente: isoniazida 9 meses o rifampicina 4 meses","TB activa: regimen de 4 farmacos por 6 meses (isoniazida, rifampicina, pirazinamida, etambutol)","Tratamiento directamente observado (DOTS)","Es fundamental completar TODO el tratamiento"],"tratamientoEn":["Latent TB: isoniazid 9 months or rifampicin 4 months","Active TB: 4-drug regimen for 6 months (isoniazid, rifampicin, pyrazinamide, ethambutol)","Directly observed therapy (DOTS)","Completing the FULL treatment is essential"],"prevencionEs":["Vacuna BCG en recien nacidos (en paises endemicos)","Deteccion y tratamiento de TB latente","Ventilacion adecuada","Aislamiento respiratorio de pacientes activos","Uso de mascarilla N95 en contacto con pacientes"],"prevencionEn":["BCG vaccine in newborns (in endemic countries)","Detection and treatment of latent TB","Adequate ventilation","Respiratory isolation of active patients","N95 mask use when in contact with patients"],"complicacionesEs":["TB multidrogo-resistente (MDR-TB)","Hemoptisis masiva","TB extrapulmonar (meningitis, osea, renal)","Insuficiencia respiratoria cronica"],"complicacionesEn":["Multidrug-resistant TB (MDR-TB)","Massive hemoptysis","Extrapulmonary TB (meningitis, bone, renal)","Chronic respiratory failure"],"datosClaveEs":["10 millones de nuevos casos al ano mundialmente","Solo 5-10% de infectados desarrollan TB activa","El VIH es el mayor factor de riesgo para progresion","El tratamiento incompleto genera resistencia a medicamentos","TB latente no es contagiosa"],"datosClaveEn":["10 million new cases annually worldwide","Only 5-10% of infected develop active TB","HIV is the greatest risk factor for progression","Incomplete treatment generates drug resistance","Latent TB is not contagious"],"vacunaDisponible":true},
  {"id":"inf-hepatitis-b","nombreEs":"Hepatitis B","nombreEn":"Hepatitis B","categoriaEs":"Hepatica","categoriaEn":"Hepatic","agenteEs":"Virus de hepatitis B (VHB)","agenteEn":"Hepatitis B virus (HBV)","descripcionEs":"Infeccion viral del higado que puede ser aguda o cronica. La infeccion cronica aumenta significativamente el riesgo de cirrosis y cancer hepatico. Es prevenible con vacuna.","descripcionEn":"Viral liver infection that can be acute or chronic. Chronic infection significantly increases risk of cirrhosis and liver cancer. Preventable with vaccine.","sintomasEs":["Muchos casos son asintomaticos","Ictericia (piel y ojos amarillos)","Orina oscura","Fatiga extrema","Nausea y vomito","Dolor abdominal superior derecho","Perdida de apetito"],"sintomasEn":["Many cases are asymptomatic","Jaundice (yellow skin and eyes)","Dark urine","Extreme fatigue","Nausea and vomiting","Right upper abdominal pain","Loss of appetite"],"transmisionEs":["Contacto con sangre infectada","Relaciones sexuales sin proteccion","De madre a hijo durante el parto","Agujas compartidas","Tatuajes o piercings con equipo no esterilizado"],"transmisionEn":["Contact with infected blood","Unprotected sexual intercourse","Mother to child during birth","Shared needles","Tattoos or piercings with unsterilized equipment"],"diagnosticoEs":["Antigeno de superficie (HBsAg)","Anticuerpos anti-HBs","Panel completo de hepatitis B","Pruebas de funcion hepatica","Carga viral de VHB"],"diagnosticoEn":["Surface antigen (HBsAg)","Anti-HBs antibodies","Complete hepatitis B panel","Liver function tests","HBV viral load"],"tratamientoEs":["Hepatitis B aguda: tratamiento de soporte","Hepatitis B cronica: antivirales (tenofovir, entecavir)","Monitoreo regular de funcion hepatica y carga viral","Evaluacion para cirrosis y cancer hepatico"],"tratamientoEn":["Acute hepatitis B: supportive treatment","Chronic hepatitis B: antivirals (tenofovir, entecavir)","Regular monitoring of liver function and viral load","Evaluation for cirrhosis and liver cancer"],"prevencionEs":["Vacuna contra hepatitis B (3 dosis)","Uso de preservativo","No compartir agujas ni articulos de higiene personal","Prueba de VHB en embarazadas","Inmunoglobulina y vacuna al recien nacido de madre positiva"],"prevencionEn":["Hepatitis B vaccine (3 doses)","Condom use","Do not share needles or personal hygiene items","HBV testing in pregnant women","Immunoglobulin and vaccine to newborn of positive mother"],"complicacionesEs":["Hepatitis cronica","Cirrosis hepatica","Carcinoma hepatocelular","Insuficiencia hepatica fulminante (rara en aguda)"],"complicacionesEn":["Chronic hepatitis","Liver cirrhosis","Hepatocellular carcinoma","Fulminant hepatic failure (rare in acute)"],"datosClaveEs":["296 millones de personas viven con hepatitis B cronica","90% de neonatos infectados desarrollan infeccion cronica vs 5% de adultos","La vacuna es 95% efectiva","La coinfeccion VIH-VHB acelera el dano hepatico"],"datosClaveEn":["296 million people live with chronic hepatitis B","90% of infected neonates develop chronic infection vs 5% of adults","Vaccine is 95% effective","HIV-HBV coinfection accelerates liver damage"],"esITS":true,"vacunaDisponible":true},
  {"id":"inf-vih","nombreEs":"VIH/SIDA","nombreEn":"HIV/AIDS","categoriaEs":"Inmunodeficiencia","categoriaEn":"Immunodeficiency","agenteEs":"Virus de inmunodeficiencia humana (VIH-1, VIH-2)","agenteEn":"Human immunodeficiency virus (HIV-1, HIV-2)","descripcionEs":"Infeccion viral cronica que ataca el sistema inmunologico, especificamente los linfocitos CD4. Sin tratamiento progresa a SIDA. Con tratamiento antirretroviral moderno, las personas con VIH tienen expectativa de vida casi normal.","descripcionEn":"Chronic viral infection that attacks the immune system, specifically CD4 lymphocytes. Without treatment progresses to AIDS. With modern antiretroviral treatment, people with HIV have near-normal life expectancy.","sintomasEs":["Infeccion aguda: fiebre, erupciones, dolor de garganta (2-4 semanas)","Fase latente: puede ser asintomatica por anos","SIDA: infecciones oportunistas, perdida de peso, diarrea cronica","Linfadenopatia generalizada","Candidiasis oral recurrente"],"sintomasEn":["Acute infection: fever, rash, sore throat (2-4 weeks)","Latent phase: can be asymptomatic for years","AIDS: opportunistic infections, weight loss, chronic diarrhea","Generalized lymphadenopathy","Recurrent oral candidiasis"],"transmisionEs":["Relaciones sexuales sin proteccion (vaginal, anal, oral)","Sangre contaminada","De madre a hijo (embarazo, parto, lactancia)","Agujas compartidas","NO por: besos, abrazos, mosquitos, compartir alimentos"],"transmisionEn":["Unprotected sexual intercourse (vaginal, anal, oral)","Contaminated blood","Mother to child (pregnancy, birth, breastfeeding)","Shared needles","NOT through: kissing, hugging, mosquitoes, sharing food"],"diagnosticoEs":["Prueba rapida de VIH (resultado en 20 min)","ELISA de 4ta generacion (antigeno/anticuerpo)","Confirmacion con Western blot o carga viral","Conteo de CD4 y carga viral para monitoreo"],"diagnosticoEn":["Rapid HIV test (result in 20 min)","4th generation ELISA (antigen/antibody)","Confirmation with Western blot or viral load","CD4 count and viral load for monitoring"],"tratamientoEs":["Terapia antirretroviral (TAR) de por vida","Regimen tipico: 2-3 medicamentos en una pastilla diaria","Inicio inmediato al diagnostico","Meta: carga viral indetectable = intransmisible (I=I)","Adherencia estricta es fundamental"],"tratamientoEn":["Lifelong antiretroviral therapy (ART)","Typical regimen: 2-3 medications in one daily pill","Immediate start upon diagnosis","Goal: undetectable viral load = untransmittable (U=U)","Strict adherence is fundamental"],"prevencionEs":["Uso consistente de preservativos","PrEP (profilaxis preexposicion) para personas de alto riesgo","PEP (profilaxis postexposicion) dentro de 72 horas","Pruebas regulares de VIH","Tratamiento como prevencion (indetectable = intransmisible)"],"prevencionEn":["Consistent condom use","PrEP (pre-exposure prophylaxis) for high-risk individuals","PEP (post-exposure prophylaxis) within 72 hours","Regular HIV testing","Treatment as prevention (undetectable = untransmittable)"],"complicacionesEs":["Infecciones oportunistas (pneumocystis, toxoplasmosis, TB)","Sarcoma de Kaposi y linfomas","Enfermedad cardiovascular acelerada","Nefropatia y neuropatia asociada al VIH","Deterioro neurocognitivo"],"complicacionesEn":["Opportunistic infections (pneumocystis, toxoplasmosis, TB)","Kaposi sarcoma and lymphomas","Accelerated cardiovascular disease","HIV-associated nephropathy and neuropathy","Neurocognitive decline"],"datosClaveEs":["39 millones de personas viven con VIH mundialmente","El TAR moderno permite vida normal y larga","Indetectable = Intransmisible es un hecho cientifico comprobado","El estigma sigue siendo una barrera principal para el diagnostico","PrEP es mas de 99% efectiva cuando se toma correctamente"],"datosClaveEn":["39 million people live with HIV worldwide","Modern ART allows normal, long life","Undetectable = Untransmittable is a proven scientific fact","Stigma remains a major barrier to diagnosis","PrEP is over 99% effective when taken correctly"],"esITS":true,"vacunaDisponible":false},
  {"id":"inf-dengue","nombreEs":"Dengue","nombreEn":"Dengue","categoriaEs":"Transmitida por vector","categoriaEn":"Vector-borne","agenteEs":"Virus del dengue (DENV 1-4), transmitido por Aedes aegypti","agenteEn":"Dengue virus (DENV 1-4), transmitted by Aedes aegypti","descripcionEs":"Infeccion viral transmitida por mosquitos, endemica en regiones tropicales. Puede variar desde fiebre leve hasta dengue grave con hemorragias y shock. La reinfeccion con un serotipo diferente aumenta el riesgo de dengue grave.","descripcionEn":"Mosquito-transmitted viral infection, endemic in tropical regions. Can range from mild fever to severe dengue with hemorrhage and shock. Reinfection with a different serotype increases risk of severe dengue.","sintomasEs":["Fiebre alta de inicio subito (40°C)","Dolor intenso detras de los ojos","Dolor muscular y articular severo (fiebre rompehuesos)","Erupciones cutaneas","Nausea y vomito","Sangrado de encias o nariz","Fatiga intensa"],"sintomasEn":["Sudden onset high fever (40°C)","Intense pain behind eyes","Severe muscle and joint pain (breakbone fever)","Skin rash","Nausea and vomiting","Bleeding from gums or nose","Intense fatigue"],"transmisionEs":["Picadura de mosquito Aedes aegypti infectado","Mosquito pica durante el dia, especialmente al amanecer y atardecer","No se transmite de persona a persona directamente"],"transmisionEn":["Bite of infected Aedes aegypti mosquito","Mosquito bites during daytime, especially dawn and dusk","Not transmitted directly person to person"],"diagnosticoEs":["Prueba de antigeno NS1 (primeros 5 dias)","Serologia IgM/IgG","Hemograma: leucopenia y trombocitopenia","PCR viral en fase aguda"],"diagnosticoEn":["NS1 antigen test (first 5 days)","IgM/IgG serology","CBC: leukopenia and thrombocytopenia","Viral PCR in acute phase"],"tratamientoEs":["No hay antiviral especifico","Hidratacion oral abundante","Acetaminofen para fiebre (NO aspirina ni ibuprofeno)","Monitoreo de plaquetas y hematocrito","Hospitalizacion si hay signos de alarma"],"tratamientoEn":["No specific antiviral","Abundant oral hydration","Acetaminophen for fever (NO aspirin or ibuprofen)","Platelet and hematocrit monitoring","Hospitalization if warning signs present"],"prevencionEs":["Eliminar agua estancada donde crian mosquitos","Usar repelente de insectos","Mosquiteros y mallas en ventanas","Ropa de manga larga en areas endemicas","Vacuna Dengvaxia en algunos paises para previamente infectados"],"prevencionEn":["Eliminate standing water where mosquitoes breed","Use insect repellent","Mosquito nets and window screens","Long-sleeved clothing in endemic areas","Dengvaxia vaccine in some countries for previously infected"],"complicacionesEs":["Dengue grave (hemorragico)","Sindrome de shock por dengue","Dano hepatico","Miocarditis","Encefalitis"],"complicacionesEn":["Severe dengue (hemorrhagic)","Dengue shock syndrome","Liver damage","Myocarditis","Encephalitis"],"datosClaveEs":["390 millones de infecciones al ano mundialmente","La segunda infeccion con serotipo diferente es mas peligrosa","No usar aspirina ni AINEs (aumenta riesgo de sangrado)","Signos de alarma: dolor abdominal intenso, vomito persistente, sangrado, letargia"],"datosClaveEn":["390 million infections annually worldwide","Second infection with different serotype is more dangerous","Do not use aspirin or NSAIDs (increases bleeding risk)","Warning signs: intense abdominal pain, persistent vomiting, bleeding, lethargy"],"vacunaDisponible":true},
  {"id":"inf-sifilis","nombreEs":"Sifilis","nombreEn":"Syphilis","categoriaEs":"Infeccion de transmision sexual","categoriaEn":"Sexually transmitted infection","agenteEs":"Treponema pallidum","agenteEn":"Treponema pallidum","descripcionEs":"ITS bacteriana cronica que progresa en etapas si no se trata. Puede afectar multiples organos incluyendo cerebro y corazon. Ha resurgido significativamente en anos recientes. Es curable con penicilina.","descripcionEn":"Chronic bacterial STI that progresses in stages if untreated. Can affect multiple organs including brain and heart. Has resurged significantly in recent years. Curable with penicillin.","sintomasEs":["Primaria: chancro indoloro en sitio de infeccion","Secundaria: erupciones en palmas y plantas, fiebre, linfadenopatia","Latente: sin sintomas pero serologia positiva","Terciaria: gomas, aortitis, neurosifilis"],"sintomasEn":["Primary: painless chancre at infection site","Secondary: rashes on palms and soles, fever, lymphadenopathy","Latent: no symptoms but positive serology","Tertiary: gummas, aortitis, neurosyphilis"],"transmisionEs":["Contacto sexual directo con chancro o lesiones","De madre a hijo (sifilis congenita)","Contacto con lesiones cutaneas infecciosas","Transfusion sanguinea (raro actualmente)"],"transmisionEn":["Direct sexual contact with chancre or lesions","Mother to child (congenital syphilis)","Contact with infectious skin lesions","Blood transfusion (rare currently)"],"diagnosticoEs":["Pruebas no treponemicas: RPR, VDRL (tamizaje)","Pruebas treponemicas: FTA-ABS, TP-PA (confirmacion)","Microscopio de campo oscuro en lesiones","Puncion lumbar si sospecha de neurosifilis"],"diagnosticoEn":["Nontreponemal tests: RPR, VDRL (screening)","Treponemal tests: FTA-ABS, TP-PA (confirmation)","Dark-field microscopy on lesions","Lumbar puncture if neurosyphilis suspected"],"tratamientoEs":["Penicilina benzatinica G: tratamiento de eleccion","Sifilis temprana: 1 dosis IM","Sifilis tardia o latente: 3 dosis IM semanales","Neurosifilis: penicilina IV por 10-14 dias","Alternativa si alergia: doxiciclina"],"tratamientoEn":["Benzathine penicillin G: treatment of choice","Early syphilis: 1 IM dose","Late or latent syphilis: 3 weekly IM doses","Neurosyphilis: IV penicillin for 10-14 days","Alternative if allergic: doxycycline"],"prevencionEs":["Uso consistente de preservativos","Pruebas regulares de ITS","Tratamiento de parejas sexuales","Tamizaje en embarazadas","Reduccion de parejas sexuales"],"prevencionEn":["Consistent condom use","Regular STI testing","Treatment of sexual partners","Screening in pregnant women","Reduction of sexual partners"],"complicacionesEs":["Neurosifilis (demencia, meningitis)","Sifilis cardiovascular (aneurisma aortico)","Sifilis congenita (deformidades, sordera, muerte fetal)","Gomas sifiliticas destructivas"],"complicacionesEn":["Neurosyphilis (dementia, meningitis)","Cardiovascular syphilis (aortic aneurysm)","Congenital syphilis (deformities, deafness, fetal death)","Destructive syphilitic gummas"],"datosClaveEs":["Los casos han aumentado dramaticamente en la ultima decada","Es conocida como la gran imitadora por sus multiples manifestaciones","La sifilis congenita es 100% prevenible con tamizaje prenatal","Coinfeccion con VIH es comun y complica el tratamiento","El chancro primario se cura solo pero la enfermedad progresa"],"datosClaveEn":["Cases have dramatically increased in the last decade","Known as the great imitator for its multiple manifestations","Congenital syphilis is 100% preventable with prenatal screening","HIV coinfection is common and complicates treatment","Primary chancre heals on its own but disease progresses"],"esITS":true,"vacunaDisponible":false},
  {"id":"inf-gonorrea","nombreEs":"Gonorrea","nombreEn":"Gonorrhea","categoriaEs":"Infeccion de transmision sexual","categoriaEn":"Sexually transmitted infection","agenteEs":"Neisseria gonorrhoeae","agenteEn":"Neisseria gonorrhoeae","descripcionEs":"ITS bacteriana comun que puede infectar genitales, recto y garganta. Muchos casos son asintomaticos, especialmente en mujeres. La resistencia a antibioticos es una preocupacion creciente.","descripcionEn":"Common bacterial STI that can infect genitals, rectum, and throat. Many cases are asymptomatic, especially in women. Antibiotic resistance is a growing concern.","sintomasEs":["Hombres: secrecion uretral purulenta, dolor al orinar","Mujeres: frecuentemente asintomatica, flujo vaginal anormal","Rectal: secrecion, dolor, sangrado","Faringea: dolor de garganta o asintomatica","Disuria y urgencia urinaria"],"sintomasEn":["Men: purulent urethral discharge, painful urination","Women: frequently asymptomatic, abnormal vaginal discharge","Rectal: discharge, pain, bleeding","Pharyngeal: sore throat or asymptomatic","Dysuria and urinary urgency"],"transmisionEs":["Contacto sexual vaginal, anal u oral sin proteccion","De madre a hijo durante el parto (oftalmia neonatal)","NO por besos, abrazos o compartir objetos"],"transmisionEn":["Unprotected vaginal, anal, or oral sexual contact","Mother to child during birth (neonatal ophthalmia)","NOT through kissing, hugging, or sharing objects"],"diagnosticoEs":["NAAT (prueba de amplificacion de acidos nucleicos) — estandar oro","Cultivo con antibiograma (importante para resistencia)","Puede detectarse en orina, hisopo cervical, uretral, rectal o faringeo"],"diagnosticoEn":["NAAT (nucleic acid amplification test) — gold standard","Culture with antibiogram (important for resistance)","Can be detected in urine, cervical, urethral, rectal, or pharyngeal swab"],"tratamientoEs":["Ceftriaxona 500mg IM dosis unica","Tratar siempre coinfeccion con clamidia (doxiciclina 7 dias)","Prueba de curacion 2 semanas despues","Tratar a todas las parejas sexuales de los ultimos 60 dias"],"tratamientoEn":["Ceftriaxone 500mg IM single dose","Always treat chlamydia coinfection (doxycycline 7 days)","Test of cure 2 weeks after","Treat all sexual partners from last 60 days"],"prevencionEs":["Uso correcto y consistente de preservativos","Pruebas regulares de ITS","Comunicacion abierta con parejas","Tamizaje anual en personas sexualmente activas menores de 25 anos"],"prevencionEn":["Correct and consistent condom use","Regular STI testing","Open communication with partners","Annual screening in sexually active people under 25"],"complicacionesEs":["Enfermedad inflamatoria pelvica (mujeres)","Infertilidad","Epididimitis (hombres)","Infeccion gonocicica diseminada (artritis, lesiones cutaneas)","Oftalmia neonatal"],"complicacionesEn":["Pelvic inflammatory disease (women)","Infertility","Epididymitis (men)","Disseminated gonococcal infection (arthritis, skin lesions)","Neonatal ophthalmia"],"datosClaveEs":["82 millones de nuevos casos al ano mundialmente","La resistencia a antibioticos es una amenaza emergente","El 50% de mujeres y 10% de hombres son asintomaticos","Siempre se debe tratar presuntivamente clamidia junto con gonorrea","La reinfeccion es comun sin tratamiento de parejas"],"datosClaveEn":["82 million new cases annually worldwide","Antibiotic resistance is an emerging threat","50% of women and 10% of men are asymptomatic","Chlamydia should always be presumptively treated with gonorrhea","Reinfection is common without partner treatment"],"esITS":true,"vacunaDisponible":false},
  {"id":"inf-clamidia","nombreEs":"Clamidia","nombreEn":"Chlamydia","categoriaEs":"Infeccion de transmision sexual","categoriaEn":"Sexually transmitted infection","agenteEs":"Chlamydia trachomatis","agenteEn":"Chlamydia trachomatis","descripcionEs":"La ITS bacteriana mas comun a nivel mundial. La mayoria de infecciones son asintomaticas, lo que facilita la transmision inadvertida. Es curable pero puede causar infertilidad si no se trata.","descripcionEn":"The most common bacterial STI worldwide. Most infections are asymptomatic, facilitating inadvertent transmission. Curable but can cause infertility if untreated.","sintomasEs":["75% de mujeres y 50% de hombres son asintomaticos","Flujo vaginal anormal o secrecion uretral","Dolor al orinar","Sangrado intermenstrual","Dolor pelvico o testicular","Proctitis si infeccion rectal"],"sintomasEn":["75% of women and 50% of men are asymptomatic","Abnormal vaginal discharge or urethral discharge","Painful urination","Intermenstrual bleeding","Pelvic or testicular pain","Proctitis if rectal infection"],"transmisionEs":["Contacto sexual vaginal, anal u oral sin proteccion","De madre a hijo durante el parto","NO por contacto casual"],"transmisionEn":["Unprotected vaginal, anal, or oral sexual contact","Mother to child during birth","NOT through casual contact"],"diagnosticoEs":["NAAT en orina o hisopo cervical/uretral","Tamizaje anual recomendado en mujeres menores de 25 anos","Tamizaje en embarazadas"],"diagnosticoEn":["NAAT on urine or cervical/urethral swab","Annual screening recommended in women under 25","Screening in pregnant women"],"tratamientoEs":["Doxiciclina 100mg cada 12 horas por 7 dias (primera linea)","Alternativa: azitromicina 1g dosis unica","Tratar a todas las parejas sexuales","Abstencion sexual por 7 dias durante tratamiento","Repetir prueba 3 meses despues"],"tratamientoEn":["Doxycycline 100mg every 12 hours for 7 days (first line)","Alternative: azithromycin 1g single dose","Treat all sexual partners","Sexual abstinence for 7 days during treatment","Repeat test 3 months after"],"prevencionEs":["Uso de preservativo en toda relacion sexual","Tamizaje regular especialmente menores de 25 anos","Comunicacion con parejas sobre ITS","Reduccion de parejas sexuales"],"prevencionEn":["Condom use in all sexual encounters","Regular screening especially under 25","Communication with partners about STIs","Reduction of sexual partners"],"complicacionesEs":["Enfermedad inflamatoria pelvica","Infertilidad por dano a trompas de Falopio","Embarazo ectopico","Epididimitis","Sindrome de Reiter (artritis reactiva)","Conjuntivitis y neumonia neonatal"],"complicacionesEn":["Pelvic inflammatory disease","Infertility from fallopian tube damage","Ectopic pregnancy","Epididymitis","Reiter syndrome (reactive arthritis)","Neonatal conjunctivitis and pneumonia"],"datosClaveEs":["129 millones de nuevos casos al ano mundialmente","Es la ITS reportable mas comun","La reinfeccion es muy frecuente","El tamizaje regular es la mejor estrategia de prevencion","La infertilidad por clamidia es prevenible con deteccion temprana"],"datosClaveEn":["129 million new cases annually worldwide","Most commonly reported STI","Reinfection is very frequent","Regular screening is the best prevention strategy","Chlamydia-related infertility is preventable with early detection"],"esITS":true,"vacunaDisponible":false},
  {"id":"inf-vph","nombreEs":"Virus del Papiloma Humano (VPH)","nombreEn":"Human Papillomavirus (HPV)","categoriaEs":"Infeccion de transmision sexual","categoriaEn":"Sexually transmitted infection","agenteEs":"Virus del papiloma humano (200+ tipos)","agenteEn":"Human papillomavirus (200+ types)","descripcionEs":"La ITS mas comun del mundo. La mayoria de infecciones se resuelven solas, pero los tipos de alto riesgo (16, 18) pueden causar cancer cervicouterino, anal, orofaringeo y otros. La vacuna es altamente efectiva.","descripcionEn":"The most common STI in the world. Most infections resolve on their own, but high-risk types (16, 18) can cause cervical, anal, oropharyngeal, and other cancers. Vaccine is highly effective.","sintomasEs":["La mayoria de infecciones son asintomaticas","Verrugas genitales (tipos 6, 11)","Verrugas comunes en manos o pies","Lesiones precancerosas en cervix detectadas por Papanicolaou","Papilomas laringeos (raro)"],"sintomasEn":["Most infections are asymptomatic","Genital warts (types 6, 11)","Common warts on hands or feet","Precancerous cervical lesions detected by Pap smear","Laryngeal papillomas (rare)"],"transmisionEs":["Contacto sexual (vaginal, anal, oral)","Contacto piel a piel genital","De madre a hijo durante el parto (raro)","NO requiere penetracion para transmitirse"],"transmisionEn":["Sexual contact (vaginal, anal, oral)","Genital skin-to-skin contact","Mother to child during birth (rare)","Does NOT require penetration for transmission"],"diagnosticoEs":["Papanicolaou (citologia cervical)","Prueba de VPH (deteccion de ADN viral)","Colposcopia si Papanicolaou anormal","Biopsia de lesiones sospechosas","Diagnostico visual de verrugas genitales"],"diagnosticoEn":["Pap smear (cervical cytology)","HPV test (viral DNA detection)","Colposcopy if Pap smear abnormal","Biopsy of suspicious lesions","Visual diagnosis of genital warts"],"tratamientoEs":["No hay cura para el virus; el sistema inmune lo elimina en la mayoria","Verrugas: crioterapia, imiquimod, podofilotoxina, electrocauterio","Lesiones precancerosas: LEEP, conizacion, crioterapia cervical","Seguimiento regular con Papanicolaou y prueba de VPH"],"tratamientoEn":["No cure for the virus; immune system clears it in most cases","Warts: cryotherapy, imiquimod, podophyllotoxin, electrocautery","Precancerous lesions: LEEP, conization, cervical cryotherapy","Regular follow-up with Pap smear and HPV test"],"prevencionEs":["Vacuna contra VPH: 9-26 anos (idealmente antes de inicio de actividad sexual)","Papanicolaou regular desde los 21 anos","Uso de preservativo (proteccion parcial)","Limitar numero de parejas sexuales"],"prevencionEn":["HPV vaccine: ages 9-26 (ideally before sexual activity begins)","Regular Pap smear from age 21","Condom use (partial protection)","Limit number of sexual partners"],"complicacionesEs":["Cancer cervicouterino","Cancer anal","Cancer orofaringeo","Cancer de pene y vulva","Papilomatosis respiratoria recurrente"],"complicacionesEn":["Cervical cancer","Anal cancer","Oropharyngeal cancer","Penile and vulvar cancer","Recurrent respiratory papillomatosis"],"datosClaveEs":["80% de personas sexualmente activas se infectan en algun momento","90% de infecciones se resuelven solas en 2 anos","VPH 16 y 18 causan 70% de canceres cervicales","La vacuna previene 90%+ de canceres relacionados con VPH","Hombres tambien se benefician de la vacunacion"],"datosClaveEn":["80% of sexually active people are infected at some point","90% of infections resolve on their own in 2 years","HPV 16 and 18 cause 70% of cervical cancers","Vaccine prevents 90%+ of HPV-related cancers","Men also benefit from vaccination"],"esITS":true,"vacunaDisponible":true},
  {"id":"inf-malaria","nombreEs":"Malaria (Paludismo)","nombreEn":"Malaria","categoriaEs":"Transmitida por vector","categoriaEn":"Vector-borne","agenteEs":"Plasmodium (P. falciparum, vivax, ovale, malariae, knowlesi)","agenteEn":"Plasmodium (P. falciparum, vivax, ovale, malariae, knowlesi)","descripcionEs":"Enfermedad parasitaria transmitida por mosquitos Anopheles. P. falciparum causa la forma mas grave. Es una de las principales causas de muerte en Africa subsahariana, especialmente en ninos.","descripcionEn":"Parasitic disease transmitted by Anopheles mosquitoes. P. falciparum causes the most severe form. One of the leading causes of death in sub-Saharan Africa, especially in children.","sintomasEs":["Fiebre ciclica con escalofrios intensos","Sudoracion profusa","Dolor de cabeza severo","Nausea y vomito","Dolor muscular y articular","Anemia","Esplenomegalia"],"sintomasEn":["Cyclic fever with intense chills","Profuse sweating","Severe headache","Nausea and vomiting","Muscle and joint pain","Anemia","Splenomegaly"],"transmisionEs":["Picadura de mosquito Anopheles hembra infectado","Transfusion sanguinea","De madre a hijo (congenita)","Mosquitos pican principalmente al anochecer y en la noche"],"transmisionEn":["Bite of infected female Anopheles mosquito","Blood transfusion","Mother to child (congenital)","Mosquitoes bite mainly at dusk and night"],"diagnosticoEs":["Gota gruesa y frotis de sangre periferica","Prueba rapida de diagnostico (deteccion de antigenos)","PCR para confirmacion de especie"],"diagnosticoEn":["Thick and thin blood smear","Rapid diagnostic test (antigen detection)","PCR for species confirmation"],"tratamientoEs":["P. falciparum: terapia combinada con artemisinina (ACT)","P. vivax/ovale: cloroquina + primaquina (para formas hepaticas)","Malaria severa: artesunato intravenoso","Hospitalizacion en malaria grave"],"tratamientoEn":["P. falciparum: artemisinin combination therapy (ACT)","P. vivax/ovale: chloroquine + primaquine (for liver forms)","Severe malaria: intravenous artesunate","Hospitalization for severe malaria"],"prevencionEs":["Mosquiteros impregnados con insecticida","Repelente de insectos al anochecer","Profilaxis farmacologica para viajeros","Fumigacion intradomiciliaria","Vacuna RTS,S/Mosquirix para ninos en areas endemicas"],"prevencionEn":["Insecticide-treated bed nets","Insect repellent at dusk","Chemoprophylaxis for travelers","Indoor residual spraying","RTS,S/Mosquirix vaccine for children in endemic areas"],"complicacionesEs":["Malaria cerebral","Anemia severa","Insuficiencia renal aguda","Edema pulmonar","Hipoglucemia severa","Muerte (especialmente P. falciparum)"],"complicacionesEn":["Cerebral malaria","Severe anemia","Acute renal failure","Pulmonary edema","Severe hypoglycemia","Death (especially P. falciparum)"],"datosClaveEs":["247 millones de casos al ano, 619,000 muertes (mayoria ninos africanos)","P. falciparum es la especie mas letal","La resistencia a medicamentos es un problema creciente","Viajeros deben tomar profilaxis en areas endemicas","Primera vacuna aprobada en 2021 (RTS,S)"],"datosClaveEn":["247 million cases per year, 619,000 deaths (mostly African children)","P. falciparum is the most lethal species","Drug resistance is a growing problem","Travelers should take prophylaxis in endemic areas","First vaccine approved in 2021 (RTS,S)"],"vacunaDisponible":true},
  {"id":"inf-herpes-genital","nombreEs":"Herpes Genital","nombreEn":"Genital Herpes","categoriaEs":"Infeccion de transmision sexual","categoriaEn":"Sexually transmitted infection","agenteEs":"Virus del herpes simple tipo 2 (VHS-2) y tipo 1 (VHS-1)","agenteEn":"Herpes simplex virus type 2 (HSV-2) and type 1 (HSV-1)","descripcionEs":"ITS viral cronica que causa brotes recurrentes de vesiculas dolorosas en genitales. No tiene cura pero es manejable con antivirales. La transmision puede ocurrir incluso sin sintomas visibles.","descripcionEn":"Chronic viral STI causing recurrent outbreaks of painful genital vesicles. Has no cure but is manageable with antivirals. Transmission can occur even without visible symptoms.","sintomasEs":["Primer brote: vesiculas dolorosas agrupadas en genitales","Dolor, ardor y picor en la zona afectada","Fiebre y malestar general en primer episodio","Disuria si lesiones cerca de uretra","Brotes recurrentes tipicamente mas leves","Prodromos: hormigueo o ardor antes del brote"],"sintomasEn":["First outbreak: painful grouped vesicles on genitals","Pain, burning, and itching in affected area","Fever and malaise in first episode","Dysuria if lesions near urethra","Recurrent outbreaks typically milder","Prodrome: tingling or burning before outbreak"],"transmisionEs":["Contacto directo con lesiones activas","Excrecion viral asintomatica (sin lesiones visibles)","Sexo oral (VHS-1 a genitales)","Preservativos reducen pero no eliminan el riesgo"],"transmisionEn":["Direct contact with active lesions","Asymptomatic viral shedding (no visible lesions)","Oral sex (HSV-1 to genitals)","Condoms reduce but do not eliminate risk"],"diagnosticoEs":["PCR de las lesiones (prueba mas sensible)","Cultivo viral de las vesiculas","Serologia tipo-especifica (IgG para VHS-1 y VHS-2)","La prueba del hisopo durante un brote es lo mas confiable"],"diagnosticoEn":["PCR of lesions (most sensitive test)","Viral culture from vesicles","Type-specific serology (IgG for HSV-1 and HSV-2)","Swab test during outbreak is most reliable"],"tratamientoEs":["Primer episodio: aciclovir o valaciclovir por 7-10 dias","Brotes recurrentes: valaciclovir 500mg-1g por 3-5 dias","Terapia supresiva: valaciclovir diario si 6+ brotes/ano","Terapia supresiva reduce transmision a parejas en 50%"],"tratamientoEn":["First episode: acyclovir or valacyclovir for 7-10 days","Recurrent outbreaks: valacyclovir 500mg-1g for 3-5 days","Suppressive therapy: daily valacyclovir if 6+ outbreaks/year","Suppressive therapy reduces transmission to partners by 50%"],"prevencionEs":["Uso de preservativo (reduccion parcial)","Terapia supresiva diaria en persona infectada","Evitar contacto sexual durante brotes activos","Comunicacion abierta con parejas","Abstinencia si hay lesiones activas"],"prevencionEn":["Condom use (partial reduction)","Daily suppressive therapy in infected person","Avoid sexual contact during active outbreaks","Open communication with partners","Abstinence if active lesions present"],"complicacionesEs":["Herpes neonatal (potencialmente mortal)","Meningitis herpetica","Retencion urinaria aguda","Impacto psicologico significativo","Mayor susceptibilidad al VIH"],"complicacionesEn":["Neonatal herpes (potentially fatal)","Herpes meningitis","Acute urinary retention","Significant psychological impact","Increased HIV susceptibility"],"datosClaveEs":["491 millones de personas de 15-49 anos tienen VHS-2","La mayoria de personas infectadas no sabe que tiene herpes","Excrecion viral asintomatica causa hasta 70% de transmisiones","No hay cura pero los brotes disminuyen con el tiempo","El estigma es desproporcionado a la gravedad medica"],"datosClaveEn":["491 million people aged 15-49 have HSV-2","Most infected people do not know they have herpes","Asymptomatic viral shedding causes up to 70% of transmissions","No cure but outbreaks decrease over time","Stigma is disproportionate to medical severity"],"esITS":true,"vacunaDisponible":false},
  {"id":"inf-hepatitis-c","nombreEs":"Hepatitis C","nombreEn":"Hepatitis C","categoriaEs":"Hepatica","categoriaEn":"Hepatic","agenteEs":"Virus de hepatitis C (VHC)","agenteEn":"Hepatitis C virus (HCV)","descripcionEs":"Infeccion viral del higado transmitida por sangre. El 70-80% de infecciones se vuelven cronicas. Actualmente es curable en mas del 95% de casos con antivirales de accion directa.","descripcionEn":"Blood-borne viral liver infection. 70-80% of infections become chronic. Currently curable in over 95% of cases with direct-acting antivirals.","sintomasEs":["Fase aguda: frecuentemente asintomatica","Ictericia (en 20-30% de casos agudos)","Fatiga cronica","Nausea y dolor abdominal","Orina oscura","Fase cronica: puede ser silenciosa por decadas"],"sintomasEn":["Acute phase: frequently asymptomatic","Jaundice (in 20-30% of acute cases)","Chronic fatigue","Nausea and abdominal pain","Dark urine","Chronic phase: can be silent for decades"],"transmisionEs":["Sangre contaminada (principal via)","Agujas y jeringas compartidas","Equipo medico o de tatuaje no esterilizado","De madre a hijo (5% de riesgo)","Sexual (riesgo bajo pero presente)"],"transmisionEn":["Contaminated blood (main route)","Shared needles and syringes","Unsterilized medical or tattoo equipment","Mother to child (5% risk)","Sexual (low but present risk)"],"diagnosticoEs":["Anticuerpos anti-VHC (tamizaje)","PCR de ARN-VHC (confirmacion de infeccion activa)","Genotipificacion","Evaluacion de fibrosis hepatica (FibroScan, elastografia)","Pruebas de funcion hepatica"],"diagnosticoEn":["Anti-HCV antibodies (screening)","HCV RNA PCR (confirmation of active infection)","Genotyping","Liver fibrosis evaluation (FibroScan, elastography)","Liver function tests"],"tratamientoEs":["Antivirales de accion directa (AAD): sofosbuvir/velpatasvir","Tratamiento de 8-12 semanas","Tasa de curacion mayor al 95%","Evaluacion de fibrosis antes y despues del tratamiento","Monitoreo post-tratamiento de respuesta virologica sostenida"],"tratamientoEn":["Direct-acting antivirals (DAAs): sofosbuvir/velpatasvir","8-12 week treatment","Cure rate over 95%","Fibrosis evaluation before and after treatment","Post-treatment monitoring of sustained virologic response"],"prevencionEs":["No compartir agujas ni equipo de inyeccion","Tamizaje universal al menos una vez en la vida","Equipo esterilizado para tatuajes y piercings","No hay vacuna disponible","Programas de reduccion de danos"],"prevencionEn":["Do not share needles or injection equipment","Universal screening at least once in lifetime","Sterilized equipment for tattoos and piercings","No vaccine available","Harm reduction programs"],"complicacionesEs":["Cirrosis hepatica (20-30% en 20 anos)","Carcinoma hepatocelular","Insuficiencia hepatica","Crioglobulinemia y manifestaciones extrahepaticas","Necesidad de trasplante hepatico"],"complicacionesEn":["Liver cirrhosis (20-30% in 20 years)","Hepatocellular carcinoma","Liver failure","Cryoglobulinemia and extrahepatic manifestations","Need for liver transplant"],"datosClaveEs":["58 millones de personas viven con VHC cronico","Es CURABLE en mas del 95% con tratamiento de 8-12 semanas","Los baby boomers (1945-1965) tienen mayor prevalencia","La cirrosis por VHC es la principal indicacion de trasplante hepatico","No genera inmunidad: es posible reinfectarse"],"datosClaveEn":["58 million people live with chronic HCV","CURABLE in over 95% with 8-12 week treatment","Baby boomers (1945-1965) have higher prevalence","HCV cirrhosis is the leading indication for liver transplant","Does not generate immunity: reinfection is possible"],"vacunaDisponible":false},
  {"id":"inf-mononucleosis","nombreEs":"Mononucleosis Infecciosa","nombreEn":"Infectious Mononucleosis","categoriaEs":"Viral","categoriaEn":"Viral","agenteEs":"Virus de Epstein-Barr (VEB)","agenteEn":"Epstein-Barr virus (EBV)","descripcionEs":"Infeccion viral conocida como la enfermedad del beso. Comun en adolescentes y adultos jovenes. Causa fatiga prolongada y agrandamiento del bazo.","descripcionEn":"Viral infection known as the kissing disease. Common in adolescents and young adults. Causes prolonged fatigue and spleen enlargement.","sintomasEs":["Fatiga extrema (semanas a meses)","Fiebre","Dolor de garganta severo con amigdalas inflamadas","Linfadenopatia cervical","Esplenomegalia","Erupciones si se administra amoxicilina"],"sintomasEn":["Extreme fatigue (weeks to months)","Fever","Severe sore throat with swollen tonsils","Cervical lymphadenopathy","Splenomegaly","Rash if amoxicillin is given"],"transmisionEs":["Saliva (beso, compartir bebidas)","Gotas respiratorias","Transfusion sanguinea (raro)"],"transmisionEn":["Saliva (kissing, sharing drinks)","Respiratory droplets","Blood transfusion (rare)"],"diagnosticoEs":["Monotest (prueba rapida de anticuerpos heterofilos)","Serologia especifica de VEB (VCA IgM, IgG, EBNA)","Hemograma: linfocitos atipicos"],"diagnosticoEn":["Monospot test (rapid heterophile antibody test)","Specific EBV serology (VCA IgM, IgG, EBNA)","CBC: atypical lymphocytes"],"tratamientoEs":["Reposo adecuado (semanas)","Hidratacion y analgesicos","Evitar deportes de contacto por 3-4 semanas (riesgo de rotura esplenica)","Corticoides solo si obstruccion de via aerea","NO dar amoxicilina/ampicilina"],"tratamientoEn":["Adequate rest (weeks)","Hydration and analgesics","Avoid contact sports for 3-4 weeks (splenic rupture risk)","Corticosteroids only if airway obstruction","Do NOT give amoxicillin/ampicillin"],"prevencionEs":["No hay vacuna disponible","Evitar compartir utensilios y bebidas","Buena higiene de manos"],"prevencionEn":["No vaccine available","Avoid sharing utensils and drinks","Good hand hygiene"],"complicacionesEs":["Rotura esplenica","Obstruccion de via aerea por amigdalas","Hepatitis","Sindrome de fatiga cronica (raro)","Anemia hemolitica"],"complicacionesEn":["Splenic rupture","Airway obstruction from tonsils","Hepatitis","Chronic fatigue syndrome (rare)","Hemolytic anemia"],"datosClaveEs":["95% de adultos han sido infectados por VEB","La fatiga puede durar 2-6 meses","La amoxicilina causa erupcion en 90% de pacientes con mono","Evitar deportes de contacto es crucial por riesgo de rotura de bazo","El virus permanece latente de por vida"],"datosClaveEn":["95% of adults have been infected with EBV","Fatigue can last 2-6 months","Amoxicillin causes rash in 90% of mono patients","Avoiding contact sports is crucial due to splenic rupture risk","Virus remains latent for life"],"vacunaDisponible":false}
]`);

// ── Helper functions ────────────────────────────────────────────────

export function buscarInfecciosa(query: string): InfecciosaEntry[] {
  const q = query.toLowerCase();
  return infecciosasEnciclopedia.filter(
    (e) =>
      e.nombreEs.toLowerCase().includes(q) ||
      e.nombreEn.toLowerCase().includes(q) ||
      e.categoriaEs.toLowerCase().includes(q) ||
      e.categoriaEn.toLowerCase().includes(q) ||
      e.descripcionEs.toLowerCase().includes(q) ||
      e.descripcionEn.toLowerCase().includes(q)
  );
}

export function getInfecciosaById(id: string): InfecciosaEntry | undefined {
  return infecciosasEnciclopedia.find((e) => e.id === id);
}

export function getInfecciosaPorCategoria(cat: string): InfecciosaEntry[] {
  const c = cat.toLowerCase();
  return infecciosasEnciclopedia.filter(
    (e) =>
      e.categoriaEs.toLowerCase().includes(c) ||
      e.categoriaEn.toLowerCase().includes(c)
  );
}

export function getITS(): InfecciosaEntry[] {
  return infecciosasEnciclopedia.filter((e) => e.esITS === true);
}

export function getConVacuna(): InfecciosaEntry[] {
  return infecciosasEnciclopedia.filter((e) => e.vacunaDisponible === true);
}
